Leaderboards/Myasthenia Gravis and Thymoma

Myasthenia Gravis and Thymoma

Last updated July 7, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Christopher Nelke
Heinrich Heine University Düsseldorf
2
Kameron Kooshesh
Harvard University
3
Che-Cheng Chang
Fu Jen Catholic University
4
Elba Pascual‐Goñi
Universitat Autònoma de Barcelona
5
Malvika Bhatnagar
Oxford Health NHS Foundation Trust
6
Florit Marcuse
Maastricht University Medical Centre
7
Mar Guasp
Clinical Trial Investigators
8
Florian Ingelfinger
University of Freiburg
9
Annabel M. Ruiter
Leiden University Medical Center
10
Charlotte Fenioux
Assistance Publique – Hôpitaux de Paris

Rising Stars Papers

1
Chylothorax: pathophysiology, diagnosis, and management—a comprehensive review
Journal of Thoracic Disease|2024
95 cit.
2
Explainable machine learning model for identifying key gut microbes and metabolites biomarkers associated with myasthenia gravis
Computational and Structural Biotechnology Journal|2024
13 cit.
3
Twin study dissects CXCR3+ memory B cells as non-heritable feature in multiple sclerosis
Med|2024
7 cit.
4
Development of a Machine Learning Algorithm to Correlate Lumbar Disc Height on X-rays with Disc Bulging or Herniation
Diagnostics|2024
6 cit.
5
Excellent response to anti-CD38 therapy with daratumumab in a patient with severe refractory CANOMAD
Journal of Neurology Neurosurgery & Psychiatry|2024
4 cit.
6
Digital biomechanical assessment of gait in patients with peripheral neuropathies
Journal of NeuroEngineering and Rehabilitation|2025
4 cit.
7
Adult thymectomy is associated with increased mortality risk from cancer but not cardiovascular disease
Blood Advances|2025
2 cit.
8
Progressive Encephalomyelitis With Rigidity and Myoclonus With Glycine Receptor Antibodies
Neurology Neuroimmunology & Neuroinflammation|2025
2 cit.
9
Correlation of C-Reactive Protein With Severe Fatigue in Patients With Myasthenia Gravis
Neurology Neuroimmunology & Neuroinflammation|2025
2 cit.
10
Thymopoiesis-Associated Genetic Variant Correlates with Cancer Risk and Outcome
Blood|2024
1 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Doreen Ho
Harvard University
2
Hong Vu
Health Net
3
Benjamin Frishberg
Hokkaido University Hospital
4
Raghav Govindarajan
American Academy of Neurology
5
Justine N. McCutcheon
Georgetown University Medical Center
6
Akiyuki Uzawa
Chiba University
7
Sushan Luo
Fudan University
8
Carolina Barnett
University of Toronto
9
Lubna Daniyal
University Health Network
10
B. Jane Distad
University of Washington

Emerging Leaders Papers

1
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study
The Lancet Neurology|2023
250 cit.
2
Understanding the Symptom Burden and Impact of Myasthenia Gravis from the Patient’s Perspective: A Qualitative Study
Neurology and Therapy|2022
56 cit.
3
Effectiveness of early cycles of fast-acting treatment in generalised myasthenia gravis
Journal of Neurology Neurosurgery & Psychiatry|2023
49 cit.
4
Efgartigimod for generalized myasthenia gravis: A multicenter real‐world cohort study in China
Annals of Clinical and Translational Neurology|2024
43 cit.
5
Efgartigimod as a promising add-on therapy for myasthenic crisis: a prospective case series
Frontiers in Immunology|2024
31 cit.
6
Peripheral immune landscape for hypercytokinemia in myasthenic crisis utilizing single-cell transcriptomics
Journal of Translational Medicine|2023
26 cit.
7
Outcomes of COVID-19 Infection and Vaccination Among Individuals With Myasthenia Gravis
JAMA Network Open|2023
22 cit.
8
The safety and efficacy profile of eculizumab in myasthenic crisis: a prospective small case series
Therapeutic Advances in Neurological Disorders|2024
18 cit.
9
Differentiation of malignant from benign orbital tumours using dual-energy CT
Clinical Radiology|2022
17 cit.
10
Pneumonia in myasthenia gravis: Microbial etiology and clinical management
Frontiers in Cellular and Infection Microbiology|2022
16 cit.

Current Senior Leaders

Established & currently active

Current Senior Leaders Researchers

1
Angela Vincent
University of Oxford
2
Andrew G. Engel
Thomas Jefferson University
3
Vanda A. Lennon
Mayo Clinic
4
Donald B. Sanders
Duke University
5
Jan J.G.M. Verschuuren
Leiden University Medical Center
6
Alexander Marx
Universitätsmedizin Göttingen
7
César A. Moran
The University of Texas MD Anderson Cancer Center
8
Hanns Lochmüller
University of Ottawa
9
Nils Erik Gilhus
Haukeland University Hospital
10
Socrates J. Tzartos
National and Kapodistrian University of Athens

Current Senior Leaders Papers

1
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
The Lancet|2004
3.2k cit.
2
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
The Journal of Experimental Medicine|2005
2.3k cit.
3
Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia
Brain|2010
1.3k cit.
4
Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies
Nature Medicine|2001
1.2k cit.
5
N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes
Brain|2010
1k cit.
6
Potassium channel antibody‐associated encephalopathy: a potentially immunotherapy‐responsive form of limbic encephalitis
Brain|2004
1k cit.
7
Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis
Annals of Neurology|2010
910 cit.
8
Birth Defects Original Article Series
Neurology|1970
902 cit.
9
The TREAT-NMD DMD Global Database: Analysis of More than 7,000 Duchenne Muscular Dystrophy Mutations
Human Mutation|2015
744 cit.
10
Neuromyelitis Optica Brain Lesions Localized at Sites of High Aquaporin 4 Expression
Archives of Neurology|2006
702 cit.

Reagents for Myasthenia Gravis and Thymoma

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Bio-Rad

StarBright Blue 700 Goat Anti-Mouse

#12004158
View Evidence →
Cell Signaling TechnologyEvidence 64

Phospho-Stat5 (Tyr694) (C71E5) Rabbit Monoclonal Antibody (Alexa Fluor® 647 Conjugate)

#9365$191,493
View Evidence →
Cell Signaling TechnologyEvidence 67

Myc-Tag (9B11) Mouse Monoclonal Antibody (Alexa Fluor® 594 Conjugate)

#9483$465
View Evidence →

🌟 All-Time

Most validated

Santa Cruz BiotechnologyEvidence 61

BAP1 (C-4)

#sc-28383
View Evidence →
Bio-Rad

StarBright Blue 700 Goat Anti-Rabbit

#12004161
View Evidence →
Cell Signaling TechnologyEvidence 65

c-Rel Antibody

#4727$136,317
View Evidence →